21 CFR 58.51
Specimen and data storage facilities
21 CFR 58.51 is the regulation titled “Specimen and data storage facilities” in 21 CFR Part 58, Good Laboratory Practice for Nonclinical Laboratory Studies. Since 2021, 1 FDA warning letter has cited it.
- Letters citing it
- 1 since 2021
- Jan 1 to Oct 30, 2026
- 0 against 1 on the same dates in 2025
- Most often cited with
- 21 CFR 58.130, in 1 letter
- Closed out
- 0% of these letters have a published close-out
Letters citing it, by year issued
It is a medical device letter. 2026 runs to Oct 30, 2026. Pick a year to see its letters.
- 02021
- 02022
- 02023
- 02024
- 12025
- 02026
The regulation
Read the text of 21 CFR 58.51 (eCFR, as of Sep 1, 2026)
Space shall be provided for archives, limited to access by authorized personnel only, for the storage and retrieval of all raw data and specimens from completed studies.
Text from eCFR as of Sep 1, 2026.
Cited alongside it
Regulations that appear in the same letters as 21 CFR 58.51.
- 21 CFR 58.130Conduct of a nonclinical laboratory study1 letter cites both
- 21 CFR 58.185Reporting of nonclinical laboratory study results1 letter cites both
- 21 CFR 58.190Storage and retrieval of records and data1 letter cites both
- 21 CFR 58.202Grounds for disqualification1 letter cites both
- 21 CFR 58.33Study director1 letter cites both
- 21 CFR 58.35Quality assurance unit1 letter cites both
- 21 CFR 58.90Animal care1 letter cites both
Latest letters citing it
The letter citing 21 CFR 58.51 that FDA posted most recently.
See the letter citing 21 CFR 58.51 →Put this kind of reading to
work on your own records.
Botable builds and runs a custom AI layer around the software you already use, so your team can do the job you hired them for.
Counts include every citation in a letter, as the Letters filter does. How this database is built.